| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | Milligan Sandra Director | Purchase | +26,050 | +81.41%58,050 | $1.92 | $50,016 | View SEC filing | |
| 2024-06-25 | Aranda Richard Chief Medical Officer | Sale | -1,908 | -0.96%196,891 | $0.66 | $1,260 | View SEC filing | |
| 2024-06-24 | Hasnain Faheem President & CEO | Purchase | +372,000 | +7.39%5,408,073 | $0.67 | $250,282 | View SEC filing | |
| 2024-06-20 | Giraudo Bryan COO/CFO | Purchase | +100,000 | +26.32%480,010 | $0.59 | $59,110 | View SEC filing | |
| 2024-06-20 | Smith Robert Paul JR Chief Commercial Officer | Purchase | +25,000 | +100.00%25,000 | $0.60 | $15,050 | View SEC filing | |
| 2024-03-28 | Christian Waage EVP, Tech Ops and Admin | Sale | -6,430 | -1.09%585,934 | $1.16 | $7,430 | View SEC filing | |
| 2024-03-28 | Giraudo Bryan COO/CFO | Sale | -6,430 | -6.48%92,737 | $1.16 | $7,431 | View SEC filing | |
| 2024-03-28 | Hasnain Faheem President & CEO | Sale | -23,172 | -16.15%120,293 | $1.16 | $26,773 | View SEC filing | |
| 2024-03-19 | Aranda Richard Chief Medical Officer | Sale | -4,018 | -1.98%198,799 | $1.33 | $5,342 | View SEC filing | |
| 2024-03-19 | Peterson Caryn EVP, Regulatory Affairs | Sale | -4,018 | -7.46%49,833 | $1.33 | $5,343 | View SEC filing | |
| 2023-11-17 | Milligan Sandra Director | Purchase | +32,000 | +100.00%32,000 | $0.79 | $25,213 | View SEC filing | |
| 2023-11-14 | Giraudo Bryan COO/CFO | Purchase | +200,000 | +111.10%380,010 | $0.56 | $112,880 | View SEC filing | |
| 2023-06-26 | Aranda Richard Chief Medical Officer | Sale | -1,814 | -0.91%197,574 | $1.29 | $2,340 | View SEC filing | |
| 2023-04-05 | Giraudo Bryan COO/CFO | Purchase | +55,000 | +77.48%125,990 | $1.02 | $56,095 | View SEC filing | |
| 2023-03-22 | Christian Waage EVP, Tech Ops and Admin | Purchase | +18,500 | +133.21%32,388 | $1.20 | $22,145 | View SEC filing | |
| 2023-03-22 | Giraudo Bryan COO/CFO | Purchase | +50,000 | +238.21%70,990 | $0.97 | $48,435 | View SEC filing | |
| 2023-03-22 | Hasnain Faheem President & CEO | Purchase | +878,572 | +24.29%4,495,897 | $1.14 | $1,000,389 | View SEC filing | |
| 2023-03-20 | Carter Laura Chief Scientific Officer | Sale | -6,029 | -7.33%76,263 | $1.10 | $6,620 | View SEC filing | |
| 2023-03-20 | Aranda Richard Chief Medical Officer | Sale | -7,563 | -3.65%199,388 | $1.10 | $8,304 | View SEC filing | |
| 2023-03-20 | Peterson Caryn EVP, Regulatory Affairs | Sale | -7,564 | -12.32%53,851 | $1.10 | $8,305 | View SEC filing | |
| 2022-10-27 | Carter Laura Chief Scientific Officer | Sale | -4,876 | -5.59%82,292 | $12.07 | $58,868 | View SEC filing | |
| 2022-10-25 | Peterson Caryn EVP, Regulatory Affairs | Sale | -4,757 | -7.19%61,415 | $12.07 | $57,431 | View SEC filing | |
| 2022-10-25 | Carter Laura Chief Scientific Officer | Sale | -4,876 | -5.59%82,292 | $12.07 | $58,868 | View SEC filing | |
| 2022-10-25 | Aranda Richard Chief Medical Officer | Sale | -4,757 | -2.26%205,430 | $12.07 | $57,431 | View SEC filing | |
| 2022-07-15 | Carter Laura Chief Scientific Officer | Purchase | +6,934 | +8.64%87,168 | $7.21 | $49,994 | View SEC filing |
1-25 of 61
